Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort Study.

No robust increase in T RM CD8 + T cells was detected >35 days after the last treatment, although a numerical trend toward higher counts was observed (≤35 days: 3.7 cells/mm 2 vs >35 days: 8.45 cells/mm 2 ; p = 0.5) ( Figure 2C ).

also in 1,012 other papers